Colombia vs Tunisia: Cause of death, by non-communicable diseases, ages 15-59, female
Colombia
50.3%
in 2021
Tunisia
50.0%
in 2021
Colombia rank
133rd
Tunisia rank
134th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Colombia
- Tunisia
How they compare
Colombia currently reports 50.3% against 50.0% in Tunisia, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Tunisia ahead.
Colombia ranks 133rd and Tunisia ranks 134th of 185 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 64.9% | 70.3% | 5.4% | Tunisia |
| 2010s | 72.3% | 77.4% | 5.1% | Tunisia |
| 2020s | 57.3% | 62.9% | 5.5% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Colombia or Tunisia?
- Colombia, at 50.3% against 50.0% in Tunisia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Colombia and Tunisia?
- 0.3%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Tunisia?
- 6 years are reported by both, from 2000 to 2021.
- How do Colombia and Tunisia rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Colombia ranks 133rd and Tunisia ranks 134th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.